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"Platelet concentrates" (PCs) boleh disediakan daripada darah utuh (RDP) atau 
daripada teknik apheresis. Untuk memastikan kualiti PCs yang baik, beberapa piawai 
telah ditetapkan oleh Unit Perubatan Transfusi (UPT) dan mengikut piawai ini, PCs 
apheresis perlu mempunyai kiraan platelet lebih daripada 2 x 1011/ Unit, isipadu melebihi 
40 mL setiap 60 x 109 platelet dan kontaminasi sel darah putih (WBC) kurang daripada 
0.5 x 109/ Unit. RDP pula perlu mempunyai kiraan platelet lebih daripada 55 x 109/ Unit, 
isipadu antara 40 hingga 60 mL, kontaminasi WBC perlu kurang daripada 0.5 x 109/ Unit 
dan kontaminasi sel darah merah (RBC) kurang daripada 1.0 x 109/ Unit. Kedua-dua 
RDP dan PCs apheresis perlu bebas daripada mikroorganisma. Objektif utama kajian ini 
adalah memastikan sama ada piawai-piawai ini dipatuhi atau tidak dan membandingkan 
kontaminasi bakteria, WBC dan RBC antara PCs apheresis dan RDP. Untuk mencapai 
objektifini satu kajian prospektiftelah dibentuk untuk dijalankan di UPT dan 47 sampel 
RDP dan 47 sampel PCs apheresis telah diuji. Kami juga telah mengkaji kesan apheresis 
ke atas kiraan darah lengkap (FBC) sebelum dan selepas pendennaan, kesan dari aspek 
hemolisis dan kesan sampingan ke atas 50 pendenna yang menggunakan Haemonetics 
MCS+. Keputusan kajian menunjukkan kriteria untuk RDP dan PCs apheresis dipatuhi 
kecuali kontaminasi RBC pada kedua-dua teknik dan isipadu RDP. Kontaminasi WBC 
dan RBC pada PCs apheresis lebih tinggi daripada RDP, tetapi kontaminasi bakteria pada 
Xll 
PCs apheresis lebih rendah. Perbandingan FBC sebelum dan selepas pendermaan 
menunjukkan penurunan signifikan pada kiraan platelet manakala kiraan WBC, 
hemoglobin dan hematokrit meningkat dengan signifikan. Secara umumnya tiada 
hemolisis berlaku pada darah penderma. Toksisiti sitrat adalah kesan sampingan yang 
tidak serius tetapi paling kerap dialami. Kesimpulannya PCs apheresis dan RDP menepati 
piawai kecuali untuk kontaminasi RBC, isipadu RDP dan kontaminasi mikroorganisma. 
Apheresis platelet oleh Haemonetics MCS+ adalah teknik yang selamat dan berkesan. 
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ABSTRACT 
Platelet concentrates (PCs) can be prepared by two methods, including apheresis 
and random donor platelets (RDP). To ensure good quality of PCs, standards have been 
set up by Transfusion Medicine Unit and according to these apheresis PCs should have 
platelet count more than 2.0 x 10111 Unit, volume more than 40mL per 60 x 109 platelets 
and white blood cell (WBC) contamination less than 0.5 x I 09 I Unit. Similarly RDP 
should have platelet count more than 55 x 1091 Unit; volume within 40 to 60 mL, WBC 
contamination should be less than 0.5 x I 09 I Unit and red blood cell (RBC) 
contamination should be less than 1.0 x 1091 Unit. For both platelet apheresis and RDP 
there should be no growth of microorganism. The main objective of this study was to 
determine whether the standards were met or not and to compare the different parameters 
including contamination with bacteria, WBC and RBC between RDP and apheresis. To 
meet our objectives we designed a prospective study to be conducted in Transfusion 
Medicine Unit and 47 apheresis PCs and 47 RDP samples were collected. We also 
studied the effects of apheresis on pre- and post-donation full blood count (FBC), 
hemolysis and side effects experienced by 50 donors using Haemonetics MCS+. Results 
of our study showed that the criteria for apheresis PCs and RDP were met except for 
RBC contamination in both techniques and volume in RDP, WBC and RBC 
contaminations in apheresis PCs were unexpectedly higher than in RDP, while bacterial 
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contamination was lower in apheresis PCs. Comparison of pre- and post donation counts 
showed, significant decrease in platelet count while WBC, hemoglobin and hematocrit 
levels were significantly increased. In general no hemolysis was observed in apheresis 
donors by Haemonetics MCS+. Citrate toxicity was mild but it was the most common 
side effect during apheresis donation. We concluded that quality of apheresis PCs and 
RDP met the standards except for RBC contamination, volume of RDP and bacterial 




1.1 PLATELET CONCENTRATES (PCs). 
Platelet concentrates (PCs) are one of the primary products produced from the 
whole blood (WB). PCs prepared from WB are usually termed as "random donor platelets 
(RDP)" and the volume of it ranges from 40 to 60 mL to achieve a therapeutic dose 4 to 6 
units from different donors are pooled. An alternative of collecting PCs is by platelet 
apheresis. PCs volwne collected from thjs method range from 200 to 300 mL. Plate 1 
shows PCs collected from apheresis while Plate 2 is an example of PCs obtained from 
whole blood. 
Plate 1: Platelet concentrates collected 
from apheresis technique 
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Plate 2: Platelet concentrates derived from 
whole blood/ random donor platelets (RDP) 
1.1.1 Indications of PCs. 
Platelet concentrates are widely used for a variety of patients. Platelets are 
transfused to control or prevent bleeding associated with critically decreased circulating 
platelet numbers or functionally abnonnal platelets. Indications of PCs transfusion is 
shown in Table 1. 
Table I Indications ofPCs transfusion. 
Indications Remarks 
Thrombocytopenic patients Platelet count is less than 50 x 109 /L. 
Decreased platelet production or decreased platelet 
function. 
Cancer patient Platelet count is less than 20 X 1 o~ /L. 
Induced thrombocytopenia during chemotherapy and 
radiation. 
Thrombocytopenic Platelet count is less than 50 X 109 /L. 
preoperative patient 
Post-operative bleeding 
Post-bone marrow transplant 
recipient 
Massive transfusion. Rapid use of platelets for hemostasis and the dilution 
of the platelets by resuscitation fluids and stored blood 
can cause thrombocytopenia. 
Note: PCs transfuston ts not usually effective or contratndtcated for pattents with increased 
destruction of circulating platelets caused by autoimmune disorders such as idiopathic 
thrombocytopenic purpura {ITP). 
Source: Modern Blood Banking and Transfusion Practices, D. M. Harmening, 1997. 
Each of unit PCs should increase the platelet count 5 x 109/L to 10 x 109/L in a 
typical 70-kg individual. 
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1.1.2 Collection, preparation and storage of PCs. 
Processing of whole blood in order to prepare PCs should be done within 8 hours of 
collection. According to World Health Organization (WHO) Technical Report Series, No 
840, 1994 Annex 2 - Requirements for the collection, processing, and quality control of 
blood, blood components and plasma derivatives (Requirements for biological substances, 
No 27, Revised 1992), blood shall be obtained from the donor by means of a single 
venepuncture giving an interrupted flow of blood with minimum damage to the tissue. Also 
it is required that the time and speed of centrifugation used to separate the platelets will 
produce a suspension without visible aggregation or hemolysis. 
Same storage condition applies to both PCs of whole blood and apheresis; PCs must 
be stored at 20 - 24 oc with continuous and gentle agitation by a special agitator to avoid 
platelet activation. PCs; whether they are from whole blood or apheresis are usually 
collected or prepared by a closed system and can be stored up to 5 days. If they are 
prepared or collected from open system, they must be transfused to patients within 6 hours. 
Pooled platelet concentrates are prepared using open system and this shortened their 
recommended storage time to 4 - 6 hours. 
1.2 QUALITY CONTROL OF PCs 
Quality control is operational techniques and activities used to fulfill the 
requirements for quality. It is also an important element in quality assurance. Performing 
quality control is an essential practice in blood banks to provide a high level of safe blood 
donation and transfusion practices to regulatory agencies, accrediting agencies, blood 
donors, physicians, patients, and patients' families (Daniel M. Harmening, 1997). Quality 
control of platelet concentrates includes the aspect of its pH, platelet count, volume, 
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sterility and contamination of WBC and RBC. It is recommended by WHO in its Technical 
Report Series 1994 that PCs units shall be randomly selected at their end of shelf-life and 
tested at a regular basis. American Association of Blood Banks (AABB) standards, as 
quoted by Daniel M. Harmening, 1997 stated that 75 percent of plateletpheresis products 
tested contain a minimum of 3.0 x I oii platelets and 75% of units from RDP tested must 
contain at least 5.5 x I010 platelets at pH >6.2. The volume of RDP should be 50±10 mL 
while plateletpheresis products must be >200mL in volume. (Blaney and Howard, 2000). 
Blood component quality control used in Transfusion Medicine Unit HUSM, which is used 
as a reference standard in this study, is adapted from quality control guide of University of 
Malaya, National Blood Center and AABB. Table 2 shows the summary for quality control 
ofPCs applied by Transfusion Medicine Unit HUSM. 
Table 2: PCs quality control applied by Transfusion Medicine Unit HUSM. 
Component Parameters Quality requirements Frequency 
checked 
Platelet concentrates Volume 50± IOmL 1% of annual 
or RDP (random production with a 
units) Platelet count >55 X 1 0~ /Unit 
.. 
of 10 mtntmum 
units per month 
RBC residuals <1.0 x IO~/Unit 
WBC residuals <0.5 x 10~/unit 
pH >6.0 
Sterility No growth of bacteria 
Plateletpheresis Volume >40mL per 60 X I09 I% of annual 
platelets production with a 
Platelet count > 200 x I o~ /Unit 
.. 
of IO mtrumum 
units per month 
WBC residuals <0.5 x 10~/Unit 
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1.3 APHERESIS. 
Apheresis is defined as withdrawal of blood from a donor, with a portion (plasma, 
leukocytes, platelets, etc.) being separated and retained and the remainder retransfused into 
the donor (Dorland's Medical Dictionary, 26th edition, 2001). Therefore collection of 
platelet by apheresis is termed as plateletpheresis. 
1.3 .1 History and development of apheresis in Transfusion Medicine Unit, HUSM. 
Increasing needs of PCs, especially PCs that can be collected from a single donor 
along with the increase in usage of plateletpheresis technique in Malaysia lead to the 
application of this technique in Transfusion Medicine Unit HUSM. Apheresis technique 
had begun in this unit since 4th April 2001. Currently there is an average of 5 donors 
donating platelets and plasma by apheresis technique in every week. Apheresis is mainly 
used to collect plasma and platelets from donors and occasionally used for therapeutic 
purposes. 
1.3.2 Haemonetics MCS+ 
Currently two Haemonetics MCS+ apheresis machines are being used in 
Transfusion Medicine Unit HUSM. This machine employs the system of intermittent-flow 
centrifugation (IFC); the process of drawing of whole blood, separating into components, 
retention of desired components and reinfusion of undesired components to the donor 
needs to be done in one complete cycle before beginning the next cycle. Separation occurs 
when the anti-coagulated blood enters a disposable centrifugation bowl which is then 
subjected to various centrifugal forces resulting in the separation of the blood into its 
various components. In Transfusion Medicine Unit HUSM, Haemonetics MCS+ machines 
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are programmed to collect platelet and plasma products, but they are also able to collect red 
blood cells, leukocytes and peripheral blood stem cells. Plate 3 shows a photograph of 
Haemonetics MCS+ apheresis machine. Figure 1 shows a diagram of cross-section of 
Haemonetics MCS+ centrifuge bowl. 
Plate 3: Haemonetics MCS+ 
apheresis machine 
¢"VYLET PORT 
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Figure 1: Cross-section ofHaemonetics 
MCS+ centrifuge bowl. 
1.3.3. Advantages and quality of plateletpheresis 
This technique is said to have more advantages compared to whole blood collection 
technique. A standard platelet concentrates from apheresis contains 3.0 X 1011 platelet, 
while a standard platelet concentrates from whole blood donation has 5.5 X 10 10 platelet. 
By collecting a large volume of PCs from a single donor, donor exposure is reduced, thus 
the risk of disease transmission and exposure to foreign antigens also can be reduced. 
Besides, a therapeutic dose can be obtained with special characteristics, such as being 
HLA-matched or IgA-deficient (Ritchard G.Cable and Richard L. Edwards, 2001). 
Apheresis PCs are usually collected from an HLA-matched donor to transfuse it to a patient 
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who had developed refractoriness or unresponsive to RDP transfusion. This is because the 
patient had developed alloantibodies to foreign platelet antigen or HLA due to frequent 
PCs transfusions. As body system is able to replace the loss of the donated platelets within 
2 days, platelet apheresis donors can donate up to every 2 weeks compared to whole blood 
technique which enables donations only once in three months. 
A study is carried out by Eugenia Vasconcelos eta/., 2003 on quality of platelet 
concentrates derived by platelet rich plasma, huffy coat and apheresis and they concluded 
that platelets derived from these three methods differ in terms of in vitro functional 
activity, aggregation states and storage characteristics, as measured by automated cell 
counters and pH assessment. This may be related to either differences in the subpopulation 
of platelets and leucocytes recovered or the processing/storage-induced cellular damage. 
Leitner GC et a!. in 2003 in their study reported that the P-selectin expression on 
multi component collection platelets (collected by MCS+ device) was within the range ofP-
selectin found in platelet concentrates obtained by other apheresis devices. In this study, 
platelet count and PCs volume were among the parameters that were used to assess the 
quality ofPCs collected by Haemonetics MCS+ and RDP. 
1.3.4. Leukodepletion 
The prevention of transfusion reactions and transmission of infectious diseases 
partly relies on the systematic removal of leukocytes. The quality of leukodepletion is 
dependent on the filtration rate, which should be as slow as possible, as quoted by Daniel 
Kientz et a/., 2001. A study which they conducted in 200 1 showed that residual leukocyte 
level in platelet concentrates collected by Haemonetics MCS+ is approximately 1 x 1 Q5 1 
Unit. 
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Seghatchian J. et a!., 2002 in their study on characterization of causes of 
leukodepletion failures said that based on the large scale United Kingdom's statistical 
process monitoring data, leukodepletion rate is estimated to be about 20% at 1 x 106 and less 
than 3% at 5x106 by flowcytometry. 
Another study of whole blood WBC-reduction filter reported the mean and 
maximum whole blood-derived PCs WBC counts after filtration were 0.08 x 106 and 0.3 x 
106, respectively per filtered unit, which meets current standard. (Larsson eta!., 2001). 
R. Moog and N. Muller, 1999 evaluated performance of three blood cell separators 
(Amicus, AS. TEC 204 and Haemonetics MCS+) on white cell reduction during 
plateletpheresis and reported that MCS+ gave the lowest WBC count and does not exceed I 
X 106/ Unit. 
Maximum standard requirement of WBC reduction varies from one country to 
another. France required that maximal residual leukocytes for both red cell and apheresis 
platelet concentrates are 1 x 106 per filtered unit (G. Andreu eta!., 1998). Leukocyte poor 
PCs with leukocytes <5 x 106 may be assumed to fulfill the specification of the Guide to 
The Preparation, Use and Quality Assurance of The Council of Europe, as reported by H. 
Olthuis eta!, 1998. 
1.3.5 Full blood count of the donors. 
Besides the issue of leukodepletion, sustained decrease of platelet count have been 
documented to occur in regular plateletpheresis donors as reported by Ellen F Lazarus et 
a!., 200 1. Another study done by Cengiz Beyan et a!. in 2003 on effect of plateletpheresis 
on donor full blood count (FBC) values using three different cell separator system also 
revealed that WBC, hemoglobin (Hb ), hematocrit (Hct) and platelets were decreased 
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significantly. However, J. Ringwald eta!, 2003 found no significant decrease in platelet 
count and no significant increase of WBC, Hct and Hb after donation. Therefore one of the 
aims this study is to compare the pre and post donation FBC in apheresis donor. From this 
test we can determine the effect of the apheresis procedure on the above mentioned 
parameters of apheresis donor. As we collect plasma and platelets but not collect RBC, this 
should result into increasing count ofHct and Hb after donation. 
1.3.6 Hemolysis during apheresis procedure 
This study also aims to detect any damage to red blood cells (RBC) that may occur 
during apheresis procedure. Centrifugation rate is from 3000 to 7000 rpm, and the rate is 
programmed according to each protocol applied (Haemonetics MCS+ General Operator 
Manual 1996). Incorrect centrifugation rate can be a factor in causing hemolysis of the 
blood. Hemolysis risk is also increased in machine malfunction or operational error (Cable 
RG and Edwards RL, 2001 ). A study also reported hemolysis as one of the immediate 
adverse effects in apheresis procedure. (McLeod BC et a/., 1998). 
1.3.7 Side effects ofplateletpheresis 
There are also other several side effects occurring to apheresis donors. During the 
procedure, the most common complaint is that people feel numbness and tingling around 
their mouths and in their fingertips, caused by citrate - one of the component of the 
anticoagulant (acid citrate dextrose) used to prevent the blood from clotting inside the 
apheresis machine. Other side effects are haematoma around the venipuncture site, allergic 
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reactions and dizziness. A growing body of evidence suggests that episodes of fainting can 
deter volunteer blood donors from returning to donate in the future. In contrast, relatively 
little is known about the effects of significantly more common mild reactions (e.g., 
faintness, dizziness, Iightheadedness) on donor retention (Christopher R. France et a/., 
2004). 
1.3.8 Bacterial contamination 
In the United States, the incidence of bacterially contaminated platelet concentrates 
is approximately I in 1000 platelet concentrates. Skin commensals such as Staphylococcus 
epidermidis and Bacillus sp. are the organisms most often implicated in platelet bacterial 
contamination (Karen-Mae T. Mitchell and Mark E. Brecher, 1999). In Malaysia the 
incidence is expected to be higher as aseptic technique is sometimes not properly applied 
during phlebotomy. Another cause of contamination is the transient presence of 
microorganism in the donor's blood, who is asymptomatic at the time of donation. In this 




The main objective of this study is to determine the quality of platelet concentrates 
collected by apheresis machine, Haemonetics MCS+ in terms of platelet count, volume, 
and WBC, RBC and bacterial contamination and comparing the contaminations with 
random donor platelets. Secondary objectives of this study are: 
o To detect any changes in FBC of apheresis donors by examining the pre and 
post donation FBC. 
o To assess hemolysis caused by apheresis procedure by examining pre- and 
post-donation ofRBC morphology and free hemoglobin in plasma. 
o To study side effects of plateletpheresis on donors 
II 
3. MATERIALS AND 1\ffiTHODS. 
3.1 MATERIALS. 
3.1.2 Approvement from Research and Ethics Committee. 
This study had obtained ethical approval from Ethical Committee, School of 
Medical Sciences, Universiti Sains Malaysia. The approval letter is included in Appendix 
A. 
3.1.3 Sample size estimation. 
Sample size required for this study was calculated by ustng the results of 
hematologic data in a study done by R. Moog and N. Muller, 1999 which is relevant to this 
study. Sample size was calculated by using Sample Size Calculation Program software. 
From the calculation, the sample required is 3 7 samples. By considering drop-out rate of 
6% and oversampling of 10 samples for each technique, 50 samples needed to be collected. 
In this study 50 blood samples before apheresis and 50 blood samples after donation have 
been taken. 47 PCs samples each; from random donor platelet and apheresis also were 
tested. 
3.1.4 Donors. 
The period of study was from September 2004 to January 2005. Apheresis donors 
who donated platelets by apheresis technique using Haemonetics MCS+ apheresis machine 
in Transfusion Medicine Unit HUSM were included in this study. Inclusion criteria for the 
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study were similar to apheresis donor qualification criteria and also the willingness of the 
donor to participate in this study. A detailed criteria of apheresis donor is attached in 
Appendix B. All donors included in this study have given informed consent. Essential 
information of the study was given to donors who participated in this study and signed 
consent form was obtained from them to fulfill the requirement of Research & Ethics 
Committee, School of Medical Sciences, Universiti Sains Malaysia. 
Sample form used to obtain signed consent is included in Appendix C. Donor's 
particulars relating to apheresis donation were taken after the procedure. A sample of form 
used to record the particulars is attached in Appendix D. During the procedure, donors 
were asked if they were experiencing any side effect. 
3.1.5 Blood agar preparation. 
This was done at Biomedical Laboratory, School of Health Sciences (PPSK). About 
10 to 40 blood agar plates were prepared in one batch depending on the number of samples 
that could be cultured in 2 weeks of time. This was done keeping in view the expiry date 
for a manually prepared blood agar which is 2 weeks after preparation. About 40 to 45 
plates of blood agar can be produced from 1 liter of blood agar. For this study a total of 
about 30 plates were used to culture RDP and 43 plates for PCs from plateletpheresis; 
occasionally 2 PCs samples were cultured on a plate. 
3.1.5.1 Whole blood. 
Expired human whole blood was used and was obtained from Transfusion Medicine 
Unit HUSM. Several universal bottles were autoclaved before the blood was put into them. 
After that the bottles were left for at least overnight at 4°C to allow separation of blood into 
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RBC and plasma. Amount of blood needed to be used was roughly estimated by this way. 
Usually if the bottles contained 40- 45 percent of RBC, 3 bottles of whole blood were 
used to prepare one liter of blood agar. 
3.5.1.2 Blood agar base preparation. 
Blood agar base powder produced commercially by Oxoid company was used. The 
amount of powder needed to be used was calculated by using this equation: 36g of powder 
= 900mL of distilled water. For example, if 500 mL blood agar was desired to be 
produced, 450 mL distilled water and 18g of powder was used. The distilled water and 
powder were then put into a 1-liter or 2-liter beaker, mixed and boiled while continuously 
stirred with spatula until the mixture or blood agar base became clear yellow in color. This 
was done to ensure proper mixing of the mixture. After that the mixture was poured into a 
500 mL Duran bottle and autoclaved. It was then allowed to cool to 55°C and the 
temperature was maintained by putting it into water bath set at 55°C. 
3.5 .1.3 Mixing of whole blood and blood agar base. 
The universal bottles containing the separated blood were allowed to warm up to 
room temperature first. After that the separated blood were mixed back to whole blood by 
gentle rolling of the universal bottle. The next step was pouring the whole blood into the 
Duran bottle containing blood agar base with proper aseptic technique applied. The Duran 
bottle was rolled to ensure proper mixing of whole blood and blood agar base. The rolling 
was gently done to avoid hemolysis. 
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3.5.1.4 Pouring of blood agar liquid into plates: 
This was done in a biosafety cabinet. After mixing, the blood agar liquid was 
poured into plates as soon as possible before the blood agar liquid turned to be solid blood 
agar. This step was also done with proper aseptic technique. After that the agar were left to 
be hardened and cooled at room temperature for 3 to 5 hours before putting the plates into a 
refrigerator to store them at 4 °C. 
3.2 METHODS. 
3.2.1 Parameter for quality control ofPCs. 
The parameters used to determine the quality of PCs include its volume, platelet, 
WBC and RBC count. 
3.2.1.1 Apheresis PCs. 
Volume reading of PCs harvested was taken from Haemonetics MCS+ machine 
parameter readings which the procedure was done with. 3 to 5 mL of PCs was taken by 
Transfusion Medicine Unit HUSM staff nurse from sample pouch attached to the platelet 
concentration bag into EDTA tube. Platelet, WBC and RBC count of the PCs were 
performed using hematological analyzer, Sysmex KX- 21N (Sysmex Co.). These were 
part of routine apheresis donation procedure. 
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3.2.1.2 RDP. 
The following data of RDP platelet concentrates (PCs) as listed below are taken 
from book record of Quality Control of Blood Components, Transfusion Medicine Unit 
HUSM dated from January 2004 to January 2005. 
• Begno. 
• Date of collection. 
• Date of quality control procedure 
• PCs volume. 
• Platelet, WBC, RBC count. 
3.2.1.3 Calculating volume ofPCs, and platelets, WBC and RBC count. 
Calculation was done according to quality control manual by Transfusion Medicine Unit 
HUSM. 
Platelets: Platelet count performed by hematological analyzer was per microliter (/J.LL) in 
unit. To convert the units from per flL to per unit PCs (/per unit), this formula was used: 
Platelets/ unit= total volume plasma /TVP (ml) x platelet count x 103 
For example: Reading obtained from analyzer was 1312 x 103/flL platelets and TVP was 
285 mL, which means 10-3 mL (1 flL) plasma/PCs contains 1312 x 103 platelets. If the 
total volume of unit is 285mL then 
1 mL of plasma/ PCs contains 1312 x 103 platelets. 
Therefore, 285 mL of plasma/ PCs would contain 
285 mL x 1312 x 103 x 103 platelets= 3.74 x 1011 platelets/ Unit. 
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RBC: RBC count performed by hematological analyzer was in microliter (/JlL) unit. To 
convert the units from per J.1L (/JlL) to per unit PCs (/per unit), this formula was used: 
RBC/ Unit= TVP (mL) x RBC count x 103 
For example, RBC count obtained from analyzer was 0.02 x 106/JlL and the volume was 
219 mL, which means1J.1L (10-3mL) plasma/ PCs contains 0.02 x 106 RBC. 
Therefore, 219 mL of plasma/ PCs would contain 
219 x 0.02 x 106 x 103 RBC = 4.38 x 109 RBC/ Unit. 
WBC: WBC count performed by hematological analyzer was in number of WBC per 
microliter (/J.1L) in unit. To convert the units from per J.1L (/J.1L) to per unit PCs (/per unit), 
this formula was used: 
WBC/ Unit= TVP (mL) x WBC count x 103• 
For example, WBC count obtained from hematological analyzer was 0.1 x 103/ JlL and 
volume was 270 mL, which means 1J.1L (10-3mL) plasmal PCs contains 0.1 x 103 WBC. 
Therefore, 270 mL of plasma/ PCs would contain 
270 x 0.1 x 103 x 103 WBC = 27 x 106 WBC/ Unit. 
Volume of apheresis PCs: PCs volume reading by Haemonetics MCS+ is in mL per unit 
bag. Standard requirement of Transfusion Medicine Unit is >40 mL per 60 x 109 platelets. 
To convert the units from mL per Unit to mL per 60 x 109 platelets, this formula was used: 
Volume per 60 x 109 platelets =Volume per bag/ Unit 




For example, PCs volume per Unit was 313mL, and platelet count was 3.0 x 1011 per Unit, 
which means the volume was 313mL per 3.0 x 1011 platelets. Therefore, volume per 60 x 
109 platelets was: 
Volume per 60 x 109 platelets= 313 x 60 = 62.6 mL. 
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3.2.2 Apheresis pre- and post-donation FBC: 
FBC of apheresis pre- and post-donation samples was also a part of routine 
apheresis procedure. 3 - 4 mL pre-donation blood sample was obtained at the blood 
sampling site of the tubing just before the apheresis procedure began by staff nurse who 
handled the procedure. The sample was then filled into an EDT A tube. After the procedure 
finished a post-donation blood sample (3 - 4 mL) was taken from the same blood sampling 
site by the same staff. Platelet, WBC, RBC and hematocrit (HCT) count was performed on 
both the pre-and post-donation samples using hematological analyzer, Sysmex KX- 21N. 
This was done in Hematology Laboratory, School of Medical Sciences. USM. 
3.2.3 Hemolysis assessment ofapheresis. 
3.2.3.1 Peripheral blood film. 
After FBC was done, a smear is made on each of the remaining blood samples of 
apheresis pre- and post-donation on clean glass slides. As it ideally should be, the smears 
were made within 3 hours of collection, but some of the samples had to be smeared more 
than 3 hours after collection (but no more than 6 hours) due to unavoidable problems faced. 
The slides were then dried by using a desiccator for 15 to 20 minutes. After that the slides 
were kept in a slide holder. Staining was done on the smears at least after 24 hours the 
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smears were made. For this purpose Wright staining was used. Staining procedure was 
done according to Hematology Laboratory HUSM standard procedure: The slides of the 
smears were flooded with Wright stain for 4 minutes, after that an equal volume of 
phosphate buffer was added, mixed well with the Wright stain by gentle blowing and were 
left for 12 minutes. The slides are then washed with running water briefly but adequately 
before drying them using a desiccator. The slides were kept for at least 24 hours after 
staining before being mounted with DPX and being put a cover slip over them. 
Microscopic evaluation of the pre- and post-donation blood films was performed by a 
hematologist. 
3.2.3.2 Free hemoglobin/ plasma hemoglobin. 
After smears were made, the remaining apheresis pre- and post donation blood 
samples in EDTA tubes were centrifuged by using refrigerated centrifuge ALC PK BO 12 to 
separate the blood into red cell and plasma components. The temperature of centrifugation 
was set to 4 °C and centrifugation rate was set at 3000rpm for 15 minutes. After that the 
hemoglobin count of the plasma was performed by using Sysmex KX- 21N. 
3.2.4 Culturing ofPCs samples. 
Culturing of samples was done in Biomedical Laboratory PPSK. Before doing so, 
the blood agars were left for 1 hour at room temperature to make sure the agars were dried. 
3.2.4.1 Apheresis. 
After sampling of the PCs was done on sample pouch, the remaining PCs in the 
sample pouch was kept in same storage condition as in an actual PCs; agitated and under 
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temperature between 20 -24 °C. it was kept for 5 to 7 days. The sample pouch was then 
brought to Biomedical Laboratory PPSK in a special polystyrene container which is 
suitable to maintain the temperature from 20 to 24 °C if transported within short distances. 
Before culturing was done, the sample pouch was checked to ensure no leaking occurred. 
Streaking of the samples was done in a biosafety cabinet with full aseptic technique applied 
- the biosafety cabinet was disinfected with 70% alcohol before culturing was done, wire 
loop used to streak the samples onto blood agar was sterilized by burning the end of it with 
flame before streaking and the part of sample pouch that will be cut to obtain a drop of the 
PCs was properly disinfected by 70% alcohol before cutting it with a scissor which was 
also properly disinfected by 70% alcohol. After streaking, the plates were labeled with the 
samples' bag number, sealed with parafilm and incubated in incubator Binder at 37°C 
overnight. The cultures were examined after that, and if no growth was detected, the 
cultures were incubated for another three days. Contaminated growth (e.g. fungal colonies) 
was not considered as a positive growth. In total 47 samples were cultured using the above 
mentioned technique. 
3.2.4.2 RDP. 
47 samples were randomly selected and cultured. Majority of the sampling was 
done by cutting a portion from remaining tube segment of RDP bag that had not been 
transfused yet to the patient. The PCs in the remaining tube segment was pushed into the 
bag and mixed well with the PCs in the bag. After that a little amount of the PCs were 
pushed back into the tube. The tube segment was properly sealed two times using a tube 
sealer before cutting it to ensure no leakage occurred. The cut portion of the segments was 
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1.5 to 2.5 em in length. After that the cut segment of tube was labeled with the same 
number used to label the RDP bag and kept agitated in an agitator at 20 - 24 °C for as long 
as platelet expiry time. For instance if the sampling was done on day 2 after the RDP was 
prepared, the sample was kept for another 3 days (overall storage period ofPCs are 5 days). 
Transportation of the samples to the Biomedical Laboratory PPSK and culturing of the 
samples were done in the same manner as apheresis PCs samples described above. 
3.2.4.3 Identification tests for positive growth: 
If positive growth was detected, Gram stain was done on the colonies. Catalase test 
and/ or coagulase test was/ were done to Gram positive bacteria. However, identification 
tests for Gram negative bacteria were not performed. 
3.2.5 Statistical analysis. 
Statistical analyses are done by using SPSS software version 11.5. Normality test is 
done on all results except for side effects during plateletpheresis and hemolysis assessment. 
A p value less than 0.05 was considered to be statistically significant. Independent t-test is 
used to test the equality of RBC contamination between apheresis PCs and RDP, while 
non-parametric test (Mann-Whitney test) is used to compare WBC contamination between 
apheresis PCs and RDP since the two populations are not normally distributed. Paired t-test 
was done to compare apheresis pre- and post-donation FBC. 
Figure 2 shows the flow chart of the methods used in this study as previously explained. 
21 
Apheresis Whole blood 
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47 RDP samples 
Tube segment 
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agitated, cultured on 
blood agar on day 5 
after preparation 
Figure 2: Flow chart of overall methods used in this study. 
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4. RESULTS. 
A prospective study was perfonned at the Transfusion Medicine Unit, HUSM from 
September 2004 to January 2005. Sample size was 50 healthy apheresis donors; from them 
50 pre- and 50 post-donation blood samples were analyzed and 47 PCs samples were 
analyzed. 47 RDP were randomly sampled to test for sterility and 47 RDP QC record 
perfonned by Transfusion Medicine Unit were also analyzed. From the 50 apheresis 
donors, 3 of them were female. Mean age of the donors was 38.8 years, ranging from 29 -
52 years. 44 (88%) of them were Malays, while the rest were Chinese. Frequency of 
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4.1 PCs QUALITY DETEIDvflNATION AND COMPARISON. 
4.1.1 WBC, RBC and bacterial contamination. 
Since distribution of WBC contamination of both apheresis PCs and RDP are not 
normal, non-parametric test (Mann-Whitney test) were used to compare the equality 
between them. Because of the non-normal distribution too, median and interquartile range 
(IQR) were considered instead of mean± standard deviation (SD). As shown in Table 3, in 
apheresis PCs, WBC contamination per microliter (JlL) is significantly lower than RDP. 
However, WBC contamination per Unit is significantly higher (p<O.OOI) in apheresis PCs 
compared to RDP. Standard requirement of Transfusion Medicine Unit HUSM for WBC 
contamination in both apheresis PCs and RDP is <0.5 x 109/ Unit. All units tested complied 
with this standard (Table 6). 
Contamination of RBC per flL in apheresis PCs was found to be significantly 
higher compared to RDP (p<0.001), while contamination per Unit in apheresis PCs is 
significantly far higher than RDP (p<0.001). Table 4 shows the mean± SD and 95% 
Confidence Interval for RBC contamination between the two populations while Table 5 
shows the statistical values of independent t-test used to compare the equality between the 
two means. RBC contamination requirement in RDP is <1.0 x 109/ Unit. No standard 
was established for RBC contamination in apheresis PCs. However, if RBC contamination 
requirement in RDP is applied to apheresis PCs, none of the units met the requirement, 
compared to RDP which 38% of them met the requirement (Table 6). 
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